Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Comcast reported for 9 months of 2023

10/26/23 CMCSA

Valero Energy reported for 9 months of 2023

10/26/23 VLO

Merck & Company reported for 9 months of 2023

10/26/23 MRK

Honeywell International reported for 9 months of 2023

10/26/23 HON

Headhunter may become a certification center for IT specialists

10/26/23 HEAD

VTB reported for 9 months of 2023 by IFRS

10/26/23 VTBR

Mordovenergosbyt reported for 9 months of 2023 by RAS

10/26/23 MRSB

Forbes has learned the details of negotiations on the sale of a controlling stake in Yandex

10/26/23 YNDX

Yandex announced the sale of a stake in OpenYard

10/26/23 YNDX

The TotalEnergies announced a quarterly dividend

10/26/23 TTE